BREEANN GILMORE: Open Payments
NPI 1679941884 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$955 in 46 payments from 9 companies in 2025. Trend: 2023 $1,438 · 2024 $1,252 · 2025 $955
Food & beverage: $878Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $385 |
| Janssen Biotech, Inc. | 3 | $158 |
| Madrigal Pharmaceuticals | 4 | $152 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $88 |
| Gilead Sciences, Inc. | 3 | $70 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| Ardelyx, Inc. | 1 | $23 |
| Intercept Pharmaceuticals, Inc. | 1 | $23 |
| EVOKE PHARMA, INC. | 1 | $18 |
Products named: RINVOQ, TREMFYA, REZDIFFRA, SKYRIZI, XIFAXAN, VOQUEZNA, VIBERZI, CREON.
Industry payments across AL — which companies pay providers there.
